Xencor (XNCR) Asset Writedowns and Impairment (2013 - 2025)

Xencor's (XNCR) quarterly Asset Writedowns and Impairment came in at -$8.3 million in Q4 2025, down 629.58% on a QoQ basis from $1.6 million in Q3 2025.

Xencor (XNCR) Asset Writedowns and Impairment (2013 - 2025) Analysis & Trends

Xencor (XNCR) has 13 years of Asset Writedowns and Impairment data on file, last reported at -$8.3 million in Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment changed N/A year-over-year to -$8.3 million in Q4 2025; TTM through Mar 2026 was -$4.9 million, a 204.74% decrease from a year earlier, with the FY2024 full-year figure at $20.4 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q4 2025 stood at -$8.3 million, down from $1.6 million in the prior quarter.
  • Over the last five years, Asset Writedowns and Impairment for XNCR reached as high as $20.6 million in Q1 2024 and fell as low as -$8.3 million in Q4 2025.
  • Historically, Asset Writedowns and Impairment has averaged $1.4 million across 5 years, with a median of $253500.0 in 2021.
  • Across the five-year window, Asset Writedowns and Impairment tumbled 694.69% in 2022 and jumped 944.55% in 2025, its largest moves.
  • Year by year, Asset Writedowns and Impairment stood at $207000.0 in 2021, then tumbled by 694.69% to -$1.2 million in 2022, then soared by 35.26% to -$797000.0 in 2023, then soared by 72.4% to -$220000.0 in 2024, then tumbled by 3667.27% to -$8.3 million in 2025.
  • Per Business Quant data, the three most recent Asset Writedowns and Impairment figures were -$8.3 million in Q4 2025, $1.6 million in Q3 2025, and $1.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Xencor 1.49 Bn 1.11 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 -8.29 Mn
Dec 31, 2025 -8.29 Mn
Sep 30, 2025 1.57 Mn
Sep 30, 2025 1.57 Mn
Jun 30, 2025 1.86 Mn
Jun 30, 2025 1.86 Mn
Mar 31, 2025 4.87 Mn
Mar 31, 2025 4.87 Mn
Jun 30, 2024 -220,000.00
Jun 30, 2024 -220,000.00
Mar 31, 2024 20.65 Mn
Mar 31, 2024 20.65 Mn
Dec 31, 2023 -797,000.00
Dec 31, 2023 -797,000.00
Dec 31, 2022 -1.23 Mn
Dec 31, 2022 -1.23 Mn
Sep 30, 2022 300,000.00
Sep 30, 2022 300,000.00
Jun 30, 2022 700,000.00
Jun 30, 2022 700,000.00